The Trump administration’s announcement of the first MFN agreement is a major drug pricing policy milestone. Industry and policymakers await the release of the administration’s Global Benchmark for ...
The Trump administration announced an agreement with Pfizer and unveiled a major drug pricing plan Tuesday, in which the pharma giant will sell its drugs at lower prices based on Most Favored Nation ...
On May 12, 2025, President Donald J. Trump signed an Executive Order (EO) titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” and the Department of Health and Human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results